P53 mutation correlates with cisplatin sensitivity in head and neck squamous cell carcinoma lines Presented at the American Association of Cancer Research 91st Annual Meeting, San Francisco, California, April 1–5, 2000.
dc.contributor.author | Bradford, Carol R. | en_US |
dc.contributor.author | Zhu, Shaobo | en_US |
dc.contributor.author | Ogawa, Haruko | en_US |
dc.contributor.author | Ogawa, Tetsuya | en_US |
dc.contributor.author | Ubell, Matthew | en_US |
dc.contributor.author | Narayan, Ajita | en_US |
dc.contributor.author | Johnson, Garfield | en_US |
dc.contributor.author | Wolf, Gregory T. | en_US |
dc.contributor.author | Fisher, Susan G. | en_US |
dc.contributor.author | Carey, Thomas E. | en_US |
dc.date.accessioned | 2006-04-19T14:11:23Z | |
dc.date.available | 2006-04-19T14:11:23Z | |
dc.date.issued | 2003-08 | en_US |
dc.identifier.citation | Bradford, Carol R.; Zhu, Shaobo; Ogawa, Haruko; Ogawa, Tetsuya; Ubell, Matthew; Narayan, Ajita; Johnson, Garfield; Wolf, Gregory T.; Fisher, Susan G.; Carey, Thomas E. (2003)."P53 mutation correlates with cisplatin sensitivity in head and neck squamous cell carcinoma lines Presented at the American Association of Cancer Research 91st Annual Meeting, San Francisco, California, April 1–5, 2000. ." Head & Neck 25(8): 654-661. <http://hdl.handle.net/2027.42/35126> | en_US |
dc.identifier.issn | 1043-3074 | en_US |
dc.identifier.issn | 1097-0347 | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/35126 | |
dc.identifier.uri | http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=12884349&dopt=citation | en_US |
dc.description.abstract | Background. A critical factor for successful organ preservation treatment in head and neck cancer may be selecting tumors that respond to chemotherapy and radiation. Previous results in patients indicated that tumors that overexpressed p53 were more sensitive to chemotherapy than those that did not overexpress p53. Methods. To determine the relationship of p53 mutations to sensitivity to cisplatin in vitro, 23 head and neck squamous cell carcinoma (HNSCC) cell lines were analyzed for cisplatin sensitivity, p53 expression, and p53 mutation status. Results. Mutations of the p53 gene were identified in 13 of 23 of the cell lines tested. Mutation of the p53 gene was significantly associated with high levels of expression of the p53 protein. The average ID 50 (drug dose required to inhibit 50% of cell growth) for cell lines with mutant p53 was 6.8 ΜM, whereas the average ID 50 for cell lines with wild-type p53 was 13.7 ΜM. Conclusions. These in vitro data support a role for mutation of the p53 tumor suppressor gene as a marker for response to cisplatin in HNSCC. © 2003 Wiley Periodicals, Inc. Head Neck 25: 654–661, 2003 | en_US |
dc.format.extent | 142552 bytes | |
dc.format.extent | 3118 bytes | |
dc.format.mimetype | application/pdf | |
dc.format.mimetype | text/plain | |
dc.language.iso | en_US | |
dc.publisher | Wiley Subscription Services, Inc., A Wiley Company | en_US |
dc.subject.other | Life and Medical Sciences | en_US |
dc.subject.other | Cancer Research, Oncology and Pathology | en_US |
dc.title | P53 mutation correlates with cisplatin sensitivity in head and neck squamous cell carcinoma lines Presented at the American Association of Cancer Research 91st Annual Meeting, San Francisco, California, April 1–5, 2000. | en_US |
dc.type | Article | en_US |
dc.rights.robots | IndexNoFollow | en_US |
dc.subject.hlbsecondlevel | Otolaryngology | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.contributor.affiliationum | Department of Otolaryngology–Head and Neck Surgery, 1904 Taubman Center, University of Michigan, Ann Arbor, Michigan 48109-0312 ; Department of Otolaryngology–Head and Neck Surgery, 1904 Taubman Center, University of Michigan, Ann Arbor, Michigan 48109-0312 | en_US |
dc.contributor.affiliationum | Department of Otolaryngology–Head and Neck Surgery, 1904 Taubman Center, University of Michigan, Ann Arbor, Michigan 48109-0312 | en_US |
dc.contributor.affiliationum | Department of Otolaryngology–Head and Neck Surgery, 1904 Taubman Center, University of Michigan, Ann Arbor, Michigan 48109-0312 | en_US |
dc.contributor.affiliationum | Department of Otolaryngology–Head and Neck Surgery, 1904 Taubman Center, University of Michigan, Ann Arbor, Michigan 48109-0312 | en_US |
dc.contributor.affiliationum | Department of Otolaryngology–Head and Neck Surgery, 1904 Taubman Center, University of Michigan, Ann Arbor, Michigan 48109-0312 | en_US |
dc.contributor.affiliationum | Department of Otolaryngology–Head and Neck Surgery, 1904 Taubman Center, University of Michigan, Ann Arbor, Michigan 48109-0312 | en_US |
dc.contributor.affiliationum | Department of Otolaryngology–Head and Neck Surgery, 1904 Taubman Center, University of Michigan, Ann Arbor, Michigan 48109-0312 | en_US |
dc.contributor.affiliationum | Department of Otolaryngology–Head and Neck Surgery, 1904 Taubman Center, University of Michigan, Ann Arbor, Michigan 48109-0312 | en_US |
dc.contributor.affiliationum | Department of Otolaryngology–Head and Neck Surgery, 1904 Taubman Center, University of Michigan, Ann Arbor, Michigan 48109-0312 | en_US |
dc.contributor.affiliationother | Cardinal Bernardin Cancer Center, Loyola University, Chicago, Illinois | en_US |
dc.identifier.pmid | 12884349 | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/35126/1/10274_ftp.pdf | en_US |
dc.identifier.doi | http://dx.doi.org/10.1002/hed.10274 | en_US |
dc.identifier.source | Head & Neck | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.